Replies to post #211698 on Biotech Values

[DewDiligence]

Re: RVNC additional CD data

The main distinction between today’s dataset and the dataset reported on 5/18/17 is that today’s dataset allocates patients into the low-dose (“A”) or high-dose (“B”) subgroup according to the graphic on slide #9 at http://investors.revance.com/common/download/download.cfm?companyid=AMDA-2GNRV0&fileid=943515&filekey=5F1AE320-5FE5-4FFC-9E62-85DF1EA5CBE9&filename=Phase_2_Cervical_Dystonia_W24_PR_Slides.FINAL-2.pdf .

In RVNC’s 5/18/17 presentation (#msg-131479120), patients were grouped according to the raw enrollment cohorts, which caused noisy data insofar as the ranges of doses within the three cohorts overlapped to some degree.